Relmada Therapeutics, Inc.
RLMD
$6.27
$0.559.62%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 233.96M | 93.01M | 13.89M | 20.62M | 27.06M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.38M | 977.70K | 967.70K | 474.60K | 596.40K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 235.34M | 93.98M | 14.85M | 21.09M | 27.66M |
|
|
|||||
| Total Current Assets | 235.34M | 93.98M | 14.85M | 21.09M | 27.66M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 19.50K | 19.50K | 22.00K | 22.00K | 22.00K |
| Total Assets | 235.36M | 94.00M | 14.88M | 21.12M | 27.68M |
|
|
|||||
| Total Accounts Payable | 5.73M | 1.57M | 1.45M | 1.36M | 1.27M |
| Total Accrued Expenses | 7.16M | 4.86M | 3.74M | 3.77M | 3.97M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 12.89M | 6.43M | 5.19M | 5.13M | 5.23M |
|
|
|||||
| Total Current Liabilities | 12.89M | 6.43M | 5.19M | 5.13M | 5.23M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.74M | 1.06M | 221.10K | 32.10K | 7.50K |
| Total Liabilities | 16.63M | 7.49M | 5.41M | 5.17M | 5.24M |
|
|
|||||
| Common Stock & APIC | 936.05M | 784.78M | 687.87M | 684.26M | 680.88M |
| Retained Earnings | -717.32M | -698.27M | -678.40M | -668.31M | -658.44M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 218.73M | 86.51M | 9.47M | 15.95M | 22.44M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 218.73M | 86.51M | 9.47M | 15.95M | 22.44M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 218.73M | 86.51M | 9.47M | 15.95M | 22.44M |
|
|
|||||